Login to Your Account

Deals And M&A NEWS

Janssen Pharmaceuticals Inc. is enlisting privately held RNA therapy specialist Arcturus Therapeutics Inc. to help it develop and commercialize new nucleic acid-based drugs for HBV and possibly other infectious and respiratory diseases.

HONG KONG – YL Biologics Ltd. has inked a licensing deal to distribute a biosimilar for the treatment of anemia by Korea’s CJ Healthcare Ltd. in Japan.

Symbiomix Therapeutics LLC, which saw its single asset, Solosec approved by the FDA last month to treat bacterial vaginosis, agreed to a buyout by Lupin Inc., the U.S. subsidiary of Mumbai-based Lupin Ltd., for $150 million, including $50 million up front.

More Deals And M&A Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: